Yupelri
Theravance Biopharma
Yupelri is a once-daily, nebulized maintenance medication to treat chronic obstructive pulmonary disease.
The anticholinergic medication helps the muscles around the airway in the lungs stay relaxed to prevent COPD symptoms such as wheezing, cough, chest tightness and shortness of breath.
Common side effects include cough, running nose, upper respiratory tract infection, headache and back pain.
The 18 most innovative medical devices of 2020>>
Filed Under: Drug Discovery, Drug Discovery and Development, Neurological Disease, Oncology, Orphan Drugs
Tell Us What You Think!
You must be logged in to post a comment.